Brind.

United Therapeutics' company performance was compared against the industry growth forecast.

2 reports, 2 independent Updated Aug 2
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

United Therapeutics' company performance was compared against the industry growth forecast.

Who's involved

What this event is mainly about
United Therapeutics

How it developed

Newest first. Tap a step to see who reported it.
  1. United Therapeutics' performance compared to industry growth forecast.1 source
  2. United Therapeutics appoints Martine Rothblatt as CEO and signs ASR agreements with Citibank.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.United Therapeutics Second Quarter 2025 Earnings: EPS Misses Expectations Revenue: US$798.6m (up 12% from 2Q 2024). Net income: US$309.5m (up 11% from 2Q 2024). Profit margin: 39% (in line with 2Q 20
  • Business WireUnited Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program Repurchase reflects the strength of United Therapeutics’ balance sheet and confidence in its near-term prospe